ASMC'13 Moscow
Conferences > Archives > ASMC'13 Moscow

Scientific Program

Sunday May 5, 2013
12:00Registration
14:00Pre-symposium Excursions (optional, and subject to registration)
19:30Welcome Reception
Monday May 6, 2013
08:30Opening Ceremony
Session Chair
Prof. Peter H. SEEBERGER
(MAX PLANCK INSTITUTE OF COLLOIDS AND INTERFACES, Berlin, Germany)
08:50Targeting Protein Surfaces Using Designed Proteomimetics
Prof. Andrew HAMILTON
(UNIVERSITY OF OXFORD, Oxford, United Kingdom)
09:40Design and Optimization of Pyrazinecarboxamide-Based Inhibitors of Diacylglycerol Acyltransferase 1 (DGAT1) Leading to the Clinical Candidate AZD7687
Dr Petra JOHANNESSON
(ASTRAZENECA, Mölndal, Sweden)
10:20New Inhibitors of the Enzyme Isoprenylcysteine Carboxyl Methyltransferase (ICMT)
Prof. María del Mar MARTÍN-FONTECHA
(COMPLUTENSE UNIVERSITY OF MADRID, Madrid, Spain)
10:35Coffee break and Exhibition
11:05Oligonucleotide Synthesis Interfaced with Molecular Biology and Nanotechnology
Prof. Marvin CARUTHERS
(UNIVERSITY OF COLORADO, Boulder, United States)
11:55BETting on Epigenetic Targets : From Phenotypic Discovery to First Time in Man
Dr Chun-wa CHUNG
(GLAXOSMITHKLINE, Stevenage, United Kingdom)
12:35Virtual Screening and Design of New Pharmaceutical Agents Using PASS Approach
Prof. Vladimir POROIKOV
(INSTITUTE OF BIOMEDICAL CHEMISTRY, Moscow, Russia)
12:50Lunch and Exhibition
Session Chair
Dr Laurent PROVINS
(UCB, Braine-l'Alleud, Belgium)
14:00Synthetic Organic Photochemistry in Batch and Flow
Prof. Kevin BOOKER-MILBURN
(UNIVERSITY OF BRISTOL, Bristol, United Kingdom)
14:50The Discovery of the Macrocyclic HCV NS3/4A Protease Inhibitor MK-5172
Dr Michael ROWLEY
(MERCK RESEARCH LABORATORIES, Kriens, Switzerland)
15:30Novel Synthetic Chemical Chaperones as a New Basis For Amyotrophic Lateral Sclerosis (ALS) Treatment
Prof. Arie-Lev GRUZMAN
(BAR ILAN UNIVERSITY, Ramat Gan, Israel)
15:45Discovery of Highly Potent S1P1 Receptor Antagonists with in vivo Efficacy
Dr Jean QUANCARD
(NOVARTIS, Basel, Switzerland)
16:00Coffee break and Exhibition
16:30A New Approach to Tuberculosis Research: The Lilly TB Drug Discovery Initiative
Dr Philip A. HIPSKIND
(ELI LILLY & COMPANY, Indianapolis, United States)
17:10Making Molecular Prosthetics via Iterative Cross-Coupling with MIDA Boronates
Prof. Martin D. BURKE
(UNIVERSITY OF ILLINOIS, Urbana, United States)
18:00Closing of the day
21:00Moscow by Night Tour (free of charge, but subject to registration)
Tuesday May 7, 2013
Session Chair
Prof. Hans Ulrich STILZ
(NOVO NORDISK, Malov, Denmark)
08:30Versatile Synthetic Methods: Access to Bioactive Molecules
Prof. Janine COSSY
(ESPCI PARISTECH, Paris, France)
09:20EFMC Prize for a Young Medicinal Chemist in Academia
Chemical Approaches to Biology and Therapeutics
Dr Goncalo BERNARDES
(INSTITUTO DE MEDICINA MOLECULAR, PORTUGAL & UNIVERSITY OF CAMBRIDGE, Lisbon, Portugal)
09:40EFMC Prize for a Young Medicinal Chemist in Industry
Free-Wilson and Structural Approaches to Co-Optimising Human and Rodent Isoform Potency for 11β-Hydroxysteroid Dehydrogenase Type 1 (11β -HSD1) Inhibitors
Dr Frederick GOLDBERG
(ASTRAZENECA, Macclesfield, United Kingdom)
10:00Rapid Kinase SAR Generation: an Integrated Approach to Synthesis, Screening and Molecular Design
Dr David PARRY
(CYCLOFLUIDIC LTD, United Kingdom)
10:15Coffee break and Exhibition
10:45Highly Anti-inflammatory Dendritic Polyglycerol Sulfates - a Multiple Target Approach
Prof. Rainer HAAG
(FREE UNIVERSITY BERLIN, Berlin, Germany)
11:35Peptide Chemologics
Dr Lee ROBERTS
(PFIZER, Sandwich, United Kingdom)
12:15Discovery of Thienoimidazole-Based HCV NS5A Genotype 1a and 1b Inhibitors
Dr Graeme SMITH
(VERTEX PHARMACEUTICALS, Cambridge, United States)
12:30Lunch and Exhibition
13:30Poster Session 1
Session Chair
Dr Edmond DIFFERDING
(DIFFERDING CONSULTING, Louvain-la-Neuve, Belgium)
14:30Organic Molecules as Biological Probes...an exciting journey
Prof. Cristina NEVADO
(UNIVERSITY OF ZURICH, Zurich, Switzerland)
15:20Discovery and Initial Clinical Results of [18F]-UCB-H, First PET Radiotracer Targeting Synaptic Vesicle 2A
Dr Anne VALADE
(UCB, Braine-l'Alleud, Belgium)
16:00Self-Immolative Spacers in Prodrug/Profluorophore Strategies: Determination of Kinetic Parameters for Release of Single or Multiple Substrates.
Dr Frédéric SCHMIDT
(INSTITUT CURIE, Paris, France)
16:15Synthetic Approach to Novel Melatonin Receptor Ligands
Mrs Maria VOLKOVA
(MOSCOW STATE UNIVERSITY, CHEMISTRY DEPARTMENT, Moscow, Russia)
16:30Coffee break and Exhibition
17:00The Design and Characterization of Targeted Covalent Inhibitors of Btk
Dr Eric SCHWARTZ
(CELGENE AVILOMICS RESEARCH, Cambridge, United States)
17:40P2X Receptors: ATP-Gated Ion Channels as Novel Drug Targets
Prof. Christa MÜLLER
(UNIVERSITY OF BONN, Bonn, Germany)
18:30Closing of the day
Wednesday May 8, 2013
Session Chair
Dr Rosa María RODRÍGUEZ SARMIENTO
(F. HOFFMANN-LA ROCHE, Basel, Switzerland)
08:30Harnessing Synergy Between Natural Products and Synthesis Towards Drug Discovery
Prof. Goverdhan MEHTA
(UNIVERSITY OF HYDERABAD, Hyderabad, India)
09:20Advances in Targeting Voltage-Gated Sodium Channels with Small Molecules
Dr Antonio NARDI
(GRÜNENTHAL, Aachen, Germany)
10:00Design, Synthesis and Application Of Fluorinated Amino Acids as Labels to Study the Membrane Active Peptides by Solid State 19F NMR
Dr Pavel MYKHAILIUK
(ENAMINE LTD, Kyiv, Ukraine)
10:15Coffee break and Exhibition
10:45Engineering of Small Non-Antibody Protein Scaffolds as Novel Biopharmaceuticals: from Anticalins to PASylation
Prof. Arne SKERRA
(TECHNICAL UNIVERSITY MUNICH, München, Germany)
11:35Bitopertin (RG1678), a Potent and Selective Glycine Re-Uptake Inhibitor for the Treatment of Schizophrenia
Dr Emmanuel PINARD
(F. HOFFMANN-LA ROCHE, Basel, Switzerland)
12:15Fragment-Based Design of Inhibitors of The Antituberculotic Target 1-Deoxy-D-Xylulose-5-Phosphate Synthase Exploiting an Innovative Combination of NMR Techniques
Mrs Tiziana MASINI
(UNIVERSITY OF GRONINGEN, Groningen, The Netherlands)
12:30Lunch and Exhibition
13:30Poster Session 2
Session Chair
Dr Alan D. PALKOWITZ
(ELI LILLY & CO.)
14:30New Strategies in Organic Synthesis: Recent Advances Based on Catalytic Reactions of Boron Reagents
Prof. James P. MORKEN
(BOSTON COLLEGE, Chestnut Hill, United States)
15:20Identification of a Novel Series of Orexin Receptor Antagonists with a Distinct Effect on Sleep Architecture
Dr Simona COTESTA
(NOVARTIS, Basel, Switzerland)
16:00Antibody Drug Conjugates for the Treatment of Cancer
Dr Paul POLAKIS
(GENENTECH, San Francisco, United States)
16:40Coffee break and Exhibition
17:10Metal Catalyzed Arylation of Nucleophiles
Dr Marc TAILLEFER
(ENSCM, Montpellier, France)
18:00From Organic Synthesis to Biomedical Sciences - from Polyhydroxybutyrate (PHB) to Cell-Penetrating Peptides
Prof. Dieter SEEBACH
(ETH ZURICH, Zürich, Switzerland)
18:50Closing of the day
20:00Symposium Banquet (optional, and subject to registration)
Thursday May 9, 2013
09:00Post-symposium Excursions (optional, and subject to registration)

Copyright 2019 LD Organisation sprl  |  rue Michel de Ghelderode 33/02 B-1348  Louvain-la-Neuve (Belgium)  Tel. +32 (0)10 45 47 77  |   |  VAT: BE 0464819842
Developed and powered by Antalys